SkyView Investment Advisors’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$162K Sell
42,000
-52,998
-56% -$193K 0.13% 145
2026
Q1
$388K Buy
94,998
+3,826
+4% +$19.3K 0.05% 226
2025
Q4
$617K Buy
91,172
+915
+1% +$6.41K 0.08% 184
2025
Q3
$630K Buy
90,257
+2,523
+3% +$17.5K 0.08% 179
2025
Q2
$523K Buy
87,734
+3,032
+4% +$20.2K 0.07% 194
2025
Q1
$644K Buy
84,702
+1,799
+2% +$15K 0.1% 177
2024
Q4
$798K Buy
82,903
+69,903
+538% +$545K 0.13% 134
2024
Q3
$77K Buy
13,000
+3,000
+30% +$19.9K 0.01% 242
2024
Q2
$69K Hold
10,000
0.01% 278
2024
Q1
$77K Buy
+10,000
New +$80.4K 0.01% 260

Other funds holding MDXG

SkyView Investment Advisors's MDXG Position: Q2 2026 in Review

SkyView Investment Advisors reduced its MiMedx Group (MDXG) stake by 56% in Q2 2026, selling an estimated $193K and leaving 42,000 shares worth $162K. The position accounts for 0.13% of the portfolio, ranked #145.

SkyView Investment Advisors first reported a position in MDXG in Q1 2024 and has held it in 10 quarters since. The position peaked at $798K in Q4 2024. 227 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • SkyView Investment Advisors held 42,000 shares of MiMedx Group worth $162K as of Q2 2026.
  • SkyView Investment Advisors sold 52,998 MiMedx Group shares in Q2 2026, an estimated $193K.
  • MiMedx Group made up 0.13% of SkyView Investment Advisors's portfolio in Q2 2026, its #145 holding.
  • SkyView Investment Advisors first reported a position in MiMedx Group in Q1 2024 and has held it in 10 quarters since.
  • SkyView Investment Advisors's MiMedx Group position peaked at $798K in Q4 2024.
  • 227 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on SkyView Investment Advisors's 13F filing for Q2 2026, filed 15 Sep 2026.